Monsanto Company  (MON) Trade Now »     Rate MON  -  Discuss MON  -  Add to Watch List        

Defensive Stock Opportunities Outside of Healthcare

The Panic Trade: A 20-Stock Defensive Growth Portfolio

The accompanying table presents a 20-stock defensive growth portfolio which I believe will outperform the overall market as measured by the S&P 500 Index as the current panic trade comes to an end and investors stop selling stocks regardless of their fundamentals. The average PEG ratio for this group of stocks is below one and the average dividend yield of 4.4% is nearly two times the S&P 500 ETF (SPY) yield of 2.4%. All of the stocks have a market cap over $1B with an average of just under $75B and the indust

Monsanto Company, together with its subsidiaries, provides agricultural products for farmers principally in the United States. It operates in two segments, Seeds and Genomics, and Agricultural Productivity. The Seeds and Genomics segment produces corn, soybeans, canola, and cotton seeds, as well as vegetable and fruit seeds, including tomato, pepper, eggplant, melon, cucumber, pumpkin, squash, beans, broccoli, onions, and lettuce. This segment also develops biotechnology traits that assist farmers in controlling insects and weeds, as well as provide genetic material and biotechnology trait

• Monsanto Company (NYSE: MON) today announced that it is investing in a new large-acre row crop, sugarcane, to diversify its existing core crop portfolio and to leverage its experience in bringing innovations to the agricultural marketplace through breeding and biotechnology. Monsanto announced today that it has entered into a definitive agreement to acquire Aly Participacoes Ltda., which operates the sugarcane breeding and technology companies, CanaVialis S.A. and Alellyx S.A., both of which are based in Brazil. Monsanto's $290 million acquisition of Aly Participacoes Ltda. from Votorantim

Filed under: Newsletters, Commodities, Agriculture, Stocks to Buy

"Agriculture-related stocks have been hammered; as a result, we are now buyers of Monsanto (NYSE: MON)," says Glenn Rogers in Gordon Pape's The Internet Wealth Builder.

"Monsanto just recently released solid earnings and raised guidance for the year. They are now looking for earnings of $3.58 to $3.60 a share, up from $3.37 previously.

"The company said the change reflected higher-than-expected sales and gross profit in its seeds and traits business and its Roundup and other glyphosate-based herbicide business.

"The stock is down